logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Trends & Strategies
  • Life Science & Technology Weekly 129 – Two monkeys were cloned in China to help with cancer research

Life Science & Technology Weekly 129 – Two monkeys were cloned in China to help with cancer research

NAI Life Science Weekly - www.nai500.com
Published on: Jan 25, 2018
Author: Editor
  • Share article:

Check www.nai500.com for more investment opportunities

Click here to find more details

This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and Technology Weekly, please click Here to subscribe.

Biotechnology Life Science Medical Device Pharmaceutical Technology

Related Posts

营收和利润均表现出色,这只制药股上涨还有另外一个重要原因

Soaring Demand for GLP-1 Drugs Makes Amgen and Regeneron Rising Stars

美国股市大幅下挫,IPO企业定价须合理才能吸引投资者

AI Unicorn Anthropic Nears IPO, How Can Retail Investors Get a Piece of the Action?

巨变前夜:伯克希尔万亿帝国的未来走向

Cash Reserves Decline by $31.5 Billion as Berkshire Ramps Up Both Investment and M&A in Q2

台积电股价今日为何上涨?

“Terrifying Data” Cools Fed Hawks, Adds New Fuel to Global Semiconductor Counteroffensive

从7000%到43%:比特币减半效应为何逐渐减弱?

Bitcoin Drops Below $63,000, Triggering Major ETF Capital Migration and a Shift in Institutional Allocation Logic

Druckenmiller’s $613 Million Silent Bet Is Crushing Nvidia — and It’s Not a Tech Stock

The Medical Device Industry Ushers in a Golden Era of Development, with Three Leading Stocks Leading the Market

Related News

Soaring Demand for GLP-1 Drugs Makes Amgen and Regeneron Rising Stars

1 day ago.

AI Unicorn Anthropic Nears IPO, How Can Retail Investors Get a Piece of the Action?

2 days ago.

Cash Reserves Decline by $31.5 Billion as Berkshire Ramps Up Both Investment and M&A in Q2

2 days ago.

“Terrifying Data” Cools Fed Hawks, Adds New Fuel to Global Semiconductor Counteroffensive

2 days ago.

Top Stories

Oracle Heavily Shorted, Stock Halved—Contrarian Opportunity?
Technology

Oracle Heavily Shorted, Stock Halved—Contrarian Opportunity?

Technology

OpenAI, Anthropic Slash Prices as Chinese AI Rivals Bite

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada